Verdiva Bio has dosed the first patient in a Phase [...]

Fractyl Health has reported positive one-year data from the midpoint [...]

CORXEL Pharmaceuticals reported positive Phase 2 results for oral GLP-1 [...]

Verdiva Bio has reported new preclinical data for two obesity [...]

Currax Pharmaceuticals is highlighting a peer-reviewed publication supporting the use [...]

This Nature-published study from the 23andMe Research Institute identifies genetic [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Appointment strengthens leadership team as company expands access to its [...]

Skye Bioscience has reached a key milestone in its CBeyond [...]

As debate continues over the cost and sustainability of GLP-1 [...]